These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23376019)

  • 1. Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.
    Kozma E; Gizewski ET; Tosh DK; Squarcialupi L; Auchampach JA; Jacobson KA
    Biochem Pharmacol; 2013 Apr; 85(8):1171-81. PubMed ID: 23376019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives.
    Storme J; Tosh DK; Gao ZG; Jacobson KA; Stove CP
    Biochem Pharmacol; 2018 Dec; 158():103-113. PubMed ID: 30292756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.
    Paoletta S; Tosh DK; Finley A; Gizewski ET; Moss SM; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2013 Jul; 56(14):5949-63. PubMed ID: 23789857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A
    Tosh DK; Salmaso V; Rao H; Bitant A; Fisher CL; Lieberman DI; Vorbrüggen H; Reitman ML; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA
    J Med Chem; 2020 Apr; 63(8):4334-4348. PubMed ID: 32271569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
    Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells.
    Cordeaux Y; Briddon SJ; Alexander SP; Kellam B; Hill SJ
    FASEB J; 2008 Mar; 22(3):850-60. PubMed ID: 17959910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists.
    Tosh DK; Ciancetta A; Warnick E; O'Connor R; Chen Z; Gizewski E; Crane S; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2016 Apr; 59(7):3249-63. PubMed ID: 26890707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent A
    Toti KS; Campbell RG; Lee H; Salmaso V; Suresh RR; Gao ZG; Jacobson KA
    Purinergic Signal; 2023 Sep; 19(3):565-578. PubMed ID: 35687212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    Olah ME; Gallo-Rodriguez C; Jacobson KA; Stiles GL
    Mol Pharmacol; 1994 May; 45(5):978-82. PubMed ID: 8190112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.
    Nayak A; Chandra G; Hwang I; Kim K; Hou X; Kim HO; Sahu PK; Roy KK; Yoo J; Lee Y; Cui M; Choi S; Moss SM; Phan K; Gao ZG; Ha H; Jacobson KA; Jeong LS
    J Med Chem; 2014 Feb; 57(4):1344-54. PubMed ID: 24456490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A
    Tosh DK; Salmaso V; Campbell RG; Rao H; Bitant A; Pottie E; Stove CP; Liu N; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA
    Eur J Med Chem; 2022 Jan; 228():113983. PubMed ID: 34844790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.
    Tosh DK; Finley A; Paoletta S; Moss SM; Gao ZG; Gizewski ET; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2014 Dec; 57(23):9901-14. PubMed ID: 25422861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A
    Gao ZG; Chen W; Gao RR; Li J; Tosh DK; Hanover JA; Jacobson KA
    Purinergic Signal; 2024 Oct; 20(5):559-570. PubMed ID: 38416332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.
    Tosh DK; Paoletta S; Chen Z; Moss SM; Gao ZG; Salvemini D; Jacobson KA
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3302-6. PubMed ID: 24969016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
    Melman A; Wang B; Joshi BV; Gao ZG; Castro Sd; Heller CL; Kim SK; Jeong LS; Jacobson KA
    Bioorg Med Chem; 2008 Sep; 16(18):8546-56. PubMed ID: 18752961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry.
    Kozma E; Kumar TS; Federico S; Phan K; Balasubramanian R; Gao ZG; Paoletta S; Moro S; Spalluto G; Jacobson KA
    Biochem Pharmacol; 2012 Jun; 83(11):1552-61. PubMed ID: 22402302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist.
    Stoddart LA; Vernall AJ; Briddon SJ; Kellam B; Hill SJ
    Neuropharmacology; 2015 Nov; 98():68-77. PubMed ID: 25937210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.